Cost-Effectiveness of Empagliflozin in Chronic Kidney Disease with or without Albuminuria
Clin J Am Soc Nephrol
.
2024 Sep 20.
doi: 10.2215/CJN.0000000582.
Online ahead of print.
Authors
Motoki Odawara
1
,
Hiroshi Nishi
1
,
Satoshi Kodera
2
,
Masahide Kondo
3
,
Masaomi Nangaku
1
Affiliations
1
Division of Nephrology and Endocrinology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
2
Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
3
Department of Health Care Policy and Management, Graduate School of Comprehensive Sciences, University of Tsukuba, Tsukuba, Japan.
PMID:
39733277
DOI:
10.2215/CJN.0000000582
No abstract available
Grants and funding
WINGS-LST)/University of Tokyo, Ministry of Education, Culture, Sports, Science and Technology of Japan